IgG4相关性硬化性胆管炎的研究现状

李雨涵; 向晓星

doi:10.3969/j.issn.1001-5256.2017.11.042

IgG4相关性硬化性胆管炎的研究现状

DOI: 10.3969/j.issn.1001-5256.2017.11.042

1. 大连医科大学消化内科
2. 苏北人民医院消化内科

详细信息

中图分类号: R575.7
计量
- 文章访问数: 1348
- HTML全文浏览量: 18
- PDF下载量: 354
- 被引次数: 0
出版历程
- 收稿日期: 2017-07-24
- 出版日期: 2017-11-20

Research advances in immunoglobulin G4-related sclerosing cholangitis

Department of Gastroenterology, Dalian Medical University

摘要

摘要: IgG4相关性硬化性胆管炎（IgG4-SC）是新近发现的一类发病机制不明的继发性硬化性胆管炎。以血清IgG4浓度升高、慢性进行性梗阻性黄疸、组织结构中大量IgG4阳性浆细胞和淋巴细胞弥漫或局限性浸润、纤维化和闭塞性静脉炎为特征。综述了IgG4-SC的诊断、治疗以及其与原发性硬化性胆管炎和胆管癌之间的关系。
- 免疫球蛋白G /
- 胆管炎,硬化性 /
- 综述
Abstract: Immunoglobulin G4-related sclerosing cholangitis (IgG4-SC) is a new type of secondary sclerosing cholangitis which was discovered recently and has unknown pathogenesis.IgG4-SC is characterized by an increased serum level of immunoglobulin G4 (IgG4) , chronic progressive obstructive jaundice, diffuse or local infiltration of a large number of IgG4-positive plasma cells and lymphocytes, fibrosis, and obstructive phlebitis.This article reviews the diagnosis and treatment of IgG4-SC and its association with primary sclerosing cholangitis and cholangiocarcinoma.
- immunoglobulin G /
- cholangitis, sclerosing /
- review

HTML全文

参考文献(41)

[1]MAILLETTE de BUY WENNIGER L, RAUWS EA, BEUERS U.What an endoscopist should know about immunoglobulin-G4-associated disease of the pancreas and biliary tree[J].Endoscopy, 2012, 44 (1) :66-73.

[2]DU S, LIU G, CHENG X, et al.Differential diagnosis of immunoglobulin g4-associated cholangitis from cholangiocarcinoma[J].JClin Gastroenterol, 2016, 50 (6) :501-505.

[3]NOVOTNY I, DITE P, TRNA J, et al.Immunoglobulin G4-related cholangitis:a variant of IgG4-related systemic disease[J].Dig Dis, 2012, 30 (2) :216-219.

[4]CARRUTHERS MN, STONE JH, KHOSROSHAHI A.The latest on IgG4-RD:a rapidly emerging disease[J].Curr OpinRheumatol, 2012, 24 (1) :60-69.

[5]ZEN Y, NAKANUMA Y, PORTMANN B.Immunoglobulin G4-related sclerosing cholangitis:pathologic features and histologic mimics[J].Semin Diagn Pathol, 2012, 29 (4) :205-211.

[6]OSEINI AM, CHAITEERAKIJ R, SHIRE AM, et al.Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma[J].Hepatology, 2011, 54 (3) :940-948.

[7]ZEN Y, NAKANUMA Y.IgG4 Cholangiopathy[J].Int J Hepatol, 2012, 2012:472376.

[8]HUANG YQ.Recent advances in research of immunoglobulin G4-related sclerosingcholangitis[J].World Chin J Dig, 2012, 20 (27) :2554-2561. (in Chinese) 黄颖秋.IgG4相关硬化性胆管炎的研究进展[J].世界华人消化杂志, 2012, 20 (27) :2554-2561.

[9]KAWABATA Y, HAYASHI H, YANO S, et al.Liver parenchyma transection-first approach in hemihepatectomy with en bloc caudate lobectomy for hilarcholangiocarcinoma:asafe technique to secure favorable surgical outcomes[J].J Surg Oncol, 2017, 115 (8) :963-970.

[10]ROSSI GM, ROCCO R, ACCORSI BE, et al.Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease[J].Intern Emerg Med, 2017, 12 (3) :287-299.

[11]ROMPA GT, JABLONSKA AK, GUZEK MT, et al.Sclerosing cholangitis associated with retroperitoneal fibrosis:a case of multisystem fibroinflammatory disorder[J].Hepatol Int, 2010, 4 (4) :779-783.

[12]CLENDENON JN, ARANDA-MICHEL J, KRISHNA M, et al.Recurrent liver failure caused by IgG4 associated cholangitis[J].Ann Hepatol, 2011, 10 (4) :562-564.

[13]SHU HJ, TAN B, XUE HD, et al.IgG4-related sclerosing cholangitis with autoimmune pancreatitis and periaortitis:case report and review of the literature[J].J Dig Dis, 2012, 13 (5) :280-286.

[14]SOHN JW, CHO CM, JUNG MK, et al.A case of autoimmune pancreatitis manifested by a pseudocyst and IgG4-associated cholangitis[J].Gut Liver, 2012, 6 (1) :132-135.

[15]OKAZAKI K, UCHIDA K, KOYABU M, et al.IgG4 cholangiopathy:current concept, diagnosis, and pathogenesis[J].J Hepatol, 2014, 61 (3) :690-695.

[16]RASTOGI A, BIHARI C, GROVER S, et al.Hepatobiliary IgG4cholangiopathy:case series and literature review[J].Int J SurgPathol, 2015, 23 (7) :531-536.

[17]van MOERKERCKE W, VERHAMME M, DOUBEL P, et al.Autoimmune pancreatitis and extrapancreatic manifestations of IgG4-related sclerosing disease[J].Acta Gastroenterol Belg, 2010, 73 (2) :239-246.

[18]VLACHOU PA, KHALILI K, JANG HJ, et al.IgG4-related sclerosing disease:autoimmune pancreatitis and extrapancreatic manifestations[J].Radiographics, 2011, 31 (5) :1379-1402.

[19]DIVATIA M, KIM SA, RO JY.IgG4-related sclerosing disease, an emerging entity:a review of a multi-system disease[J].Yonsei Med J, 2012, 53 (1) :15-34.

[20]SHIMOSEGAWA T, CHARI ST, FRULLONI L, et al.International consensus diagnostic criteria for autoimmune pancreatitis:guidelines of the International Association of Pancreatology[J].Pancreas, 2011, 40 (3) :352-358.

[21] CARRUTHERS MN, STONE JH, KHOSROSHAHI A.The latest on IgG4-RD:a rapidly emerging disease[J].Curr OpinRheumatol, 2012, 24 (1) :60-69.

[22]TABATA T, KAMISAWA T, HARA S, et al.Differentiating immunoglobulin G4-related sclerosing cholangitis from hilar cholangiocarcinoma[J].Gut Liver, 2013, 7 (2) :234-238.

[23] BOONSTRA K, CULVER EL, de BUY WL, et al.Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis[J].Hepatology, 2014, 59 (5) :1954-1963.

[24]TAGHAVI SA, MAJD SK, SIANATI M, et al.Prevalence of IgG-4-associated cholangiopathy based on serum IgG-4 levels in patients with primary sclerosing cholangitis and its relationship with inflammatory bowel disease[J].Turk J Gastroenterol, 2016, 27 (6) :547-552.

[25]VOSSKUHL K, NEGM A A, FRAMKE T, et al.Measurement of IgG4in bile:a new approach for the diagnosis of IgG4-associated cholangiopathy[J].Endoscopy, 2012, 44 (1) :48-52.

[26]NAKAZAWA T, ANDO T, HAYASHI K, et al.Diagnostic procedures for IgG4-related sclerosing cholangitis[J].J Hepatobiliary Pancreat Sci, 2011, 18 (2) :127-136.

[27] OKAZAKI K, UCHIDA K, KOYABU M, et al.IgG4 cholangiopathy:current concept, diagnosis, and pathogenesis[J].J Hepatol, 2014, 61 (3) :690-695.

[28]TOMIYAMA T, UCHIDA K, MATSUSHITA M, et al.Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis[J].J Gastroenterol, 2011, 46 (5) :696-704.

[29]MAILLETTE DBWL, DOORENSPLEET ME, KLARENBEEK PL, et al.Immunoglobulin G4+clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis[J].Hepatology, 2013, 57 (6) :2390-2398.

[30]BOONSTRA K, CULVER EL, de BUY WL, et al.Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis[J].Hepatology, 2014, 59 (5) :1954-1963.

[31]ALSWAT K, AL-HARTHY N, MAZRANI W, et al.The spectrum of sclerosing cholangitis and the relevance of IgG4 elevations in routine practice[J].Am J Gastroenterol, 2012, 107 (1) :56-63.

[32]NOWATARI T, KOBAYASHI A, FUKUNAGA K, et al.Recognition of other organ involvement might assist in the differential diagnosis of IgG4-associated sclerosing cholangitis without apparent pancreatic involvement:report of two cases[J].Surg Today, 2012, 42 (11) :1111-1115.

[33]SANDANAYAKE NS, SINCLAIR J, ANDREOLA F, et al.A combination of serum leucine-rich alpha-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures[J].Br J Cancer, 2011, 105 (9) :1370-1378.

[34]FERRY JA, KLEPEIS V, SOHANI AR, et al.IgG4-related orbital disease and its mimics in a western population[J].Am J Surg Pathol, 2015, 39 (12) :1688-1700.

[35]WALLACE ZS, DESHPANDE V, MATTOO H, et al.IgG4-Related disease:clinical and laboratory features in one hundred twenty-five patients[J].Arthritis Rheumatol, 2015, 67 (9) :2466-2475.

[36]EBBO M, DANIEL L, PAVIC M, et al.IgG4-related systemic disease:features and treatment response in a French cohort:results of a multicenter registry[J].Medicine (Baltimore) , 2012, 91 (1) :49-56.

[37]GRADOS A, EBBO M, JEAN E, et al.IgG4-related disease treatment in 2014:update and literature review[J].Rev Med Interne, 2015, 36 (6) :395-404.

[38]EBBO M, PATIENT M, GRADOS A, et al.Ophthalmic manifestations in IgG4-related disease:Clinical presentation and response to treatment in a French case-series[J].Medicine (Baltimore) , 2017, 96 (10) :e6205.

[39]BAE JH, KIM SH, AHN SB, et al.A case of idiopathic sclerosing mesenteritis with retroperitoneal fibrosis[J].Korean J Gastroenterol, 2011, 58 (4) :221-225.

[40]CARRUTHERS MN, TOPAZIAN MD, KHOSROSHAHI A, et al.Rituximab for IgG4-related disease:a prospective, open-label trial[J].Ann Rheum Dis, 2015, 74 (6) :1171-1177.

[41]GU WJ, ZHANG Q, ZHU J, et al.Rituximab was used to treat recurrent IgG4-related hypophysitis with ophthalmopathy as the initial presentation:a case report and literature review[J].Medicine (Baltimore) , 2017, 96 (24) :e6934.

施引文献

资源附件(0)

访问统计